Identifying the Predictive Factors of Response to PD-1 or PD-L1 Antagonists

Clinical trial NCT03412058 · TERMINATED

Trial details

NCT number: NCT03412058
Sponsor: UNICANCER
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Melanoma Non Small Cell Lung Cancer Head and Neck Squamous Cell Carcinoma

Start date: 2018-06-27
Primary completion: 2024-01-02
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.